Terms: = Brain cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Treatment
17 results:
1. Meningioma: current updates on genetics, classification, and mouse modeling.
Szulzewsky F; Thirimanne HN; Holland EC
Ups J Med Sci; 2024; 129():. PubMed ID: 38571886
[TBL] [Abstract] [Full Text] [Related]
2. Generation of mesenchymal stromal cells from urine-derived iPSCs of pediatric brain tumor patients.
Baliña-Sánchez C; Aguilera Y; Adán N; Sierra-Párraga JM; Olmedo-Moreno L; Panadero-Morón C; Cabello-Laureano R; Márquez-Vega C; Martín-Montalvo A; Capilla-González V
Front Immunol; 2023; 14():1022676. PubMed ID: 36776860
[TBL] [Abstract] [Full Text] [Related]
3. Salidroside inhibits endothelial‑mesenchymal transition via the klf4/eNOS signaling pathway.
Huang Y; Han X; Tang J; Long X; Wang X
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34368873
[TBL] [Abstract] [Full Text] [Related]
4. Loss-of-Function Mutations in TRAF7 and klf4 Cooperatively Activate RAS-Like GTPase Signaling and Promote Meningioma Development.
Najm P; Zhao P; Steklov M; Sewduth RN; Baietti MF; Pandolfi S; Criem N; Lechat B; Maia TM; Van Haver D; Corthout N; Eyckerman S; Impens F; Sablina AA
Cancer Res; 2021 Aug; 81(16):4218-4229. PubMed ID: 34215617
[TBL] [Abstract] [Full Text] [Related]
5. Associations of meningioma molecular subgroup and tumor recurrence.
Youngblood MW; Miyagishima DF; Jin L; Gupte T; Li C; Duran D; Montejo JD; Zhao A; Sheth A; Tyrtova E; Özduman K; Iacoangeli F; Peyre M; Boetto J; Pease M; Avşar T; Huttner A; Bilguvar K; Kilic T; Pamir MN; Amankulor N; Kalamarides M; Erson-Omay EZ; Günel M; Moliterno J
Neuro Oncol; 2021 May; 23(5):783-794. PubMed ID: 33068421
[TBL] [Abstract] [Full Text] [Related]
6. A narrative review of targeted therapy in meningioma, pituitary adenoma, and craniopharyngioma of the skull base.
Martinez NL; Khanna O; Farrell CJ
Chin Clin Oncol; 2020 Dec; 9(6):75. PubMed ID: 32819111
[TBL] [Abstract] [Full Text] [Related]
7. klf4
von Spreckelsen N; Waldt N; Poetschke R; Kesseler C; Dohmen H; Jiao HK; Nemeth A; Schob S; Scherlach C; Sandalcioglu IE; Deckert M; Angenstein F; Krischek B; Stavrinou P; Timmer M; Remke M; Kirches E; Goldbrunner R; Chiocca EA; Huettelmaier S; Acker T; Mawrin C
Acta Neuropathol Commun; 2020 Apr; 8(1):41. PubMed ID: 32245394
[TBL] [Abstract] [Full Text] [Related]
8. Transcriptome analysis reveals the molecular mechanisms of combined gamma-tocotrienol and hydroxychavicol in preventing the proliferation of 1321N1, SW1783, and LN18 glioma cancer cells.
Abdul Rahman A; Mokhtar NM; Harun R; Jamal R; Wan Ngah WZ
J Physiol Biochem; 2019 Nov; 75(4):499-517. PubMed ID: 31414341
[TBL] [Abstract] [Full Text] [Related]
9. Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.
Hasan T; Caragher SP; Shireman JM; Park CH; Atashi F; Baisiwala S; Lee G; Guo D; Wang JY; Dey M; Wu M; Lesniak MS; Horbinski CM; James CD; Ahmed AU
Cell Death Dis; 2019 Mar; 10(4):292. PubMed ID: 30926789
[TBL] [Abstract] [Full Text] [Related]
10. New molecular targets in meningiomas: the present and the future.
Venur VA; Santagata S; Galanis E; Brastianos PK
Curr Opin Neurol; 2018 Dec; 31(6):740-746. PubMed ID: 30379704
[TBL] [Abstract] [Full Text] [Related]
11. High-grade meningiomas: biology and implications.
Bi WL; Prabhu VC; Dunn IF
Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053
[TBL] [Abstract] [Full Text] [Related]
12. NKG2D ligands in glioma stem-like cells: expression in situ and in vitro.
Flüh C; Chitadze G; Adamski V; Hattermann K; Synowitz M; Kabelitz D; Held-Feindt J
Histochem Cell Biol; 2018 Mar; 149(3):219-233. PubMed ID: 29356965
[TBL] [Abstract] [Full Text] [Related]
13. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C
Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067
[TBL] [Abstract] [Full Text] [Related]
14. OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells.
Asadi MH; Khalifeh K; Mowla SJ
J Neurooncol; 2016 Dec; 130(3):455-463. PubMed ID: 27585657
[TBL] [Abstract] [Full Text] [Related]
15. MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Krüppel-like factor 4.
Ma J; Yao Y; Wang P; Liu Y; Zhao L; Li Z; Li Z; Xue Y
Cancer Lett; 2014 Dec; 355(1):85-95. PubMed ID: 25218589
[TBL] [Abstract] [Full Text] [Related]
16. The PGI-klf4 pathway regulates self-renewal of glioma stem cells residing in the mesenchymal niches in human gliomas.
Zhu XY; Wang L; Luan SH; Zhang HS; Huang WT; Wang NH
Neoplasma; 2014; 61(4):401-10. PubMed ID: 24645841
[TBL] [Abstract] [Full Text] [Related]
17. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
[TBL] [Abstract] [Full Text] [Related]
